The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

FluMist was produced by the AstraZeneca company. The FDA stated in a release on Friday, "FluMist is approved for the ...

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...

FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.

What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...